Britannia reports 16.6% revenue growth in Q2 FY27

Britannia Industries has announced its financial results for the second quarter and the first half of fiscal year 2026-27. The company reported a robust 16.6% year-on-year growth in revenue from operations for Q2’27, reaching Rs 5,542 Crores. Profit after tax for the quarter also saw a positive increase of 10.2%. For the half-year ended September 2026, revenue grew by 13.1% to Rs 10,506 Crores.

Britannia Industries Financial Highlights

Britannia Industries has released its performance scorecard for the second quarter (Q2’27) and the first half (H1’27) of the fiscal year 2026-27, demonstrating significant financial growth. The company has showcased a healthy increase in both revenue and profitability during the reported periods.

Q2 FY27 Performance

In the second quarter of fiscal year 2026-27, Britannia Industries recorded Revenue from Operations amounting to Rs 5,542 Crores, marking a substantial 16.6% growth compared to the same period last year. The company also achieved a 12 Months Growth of +16.6% and a +11.6% growth versus Q1’27. The Profit after Tax stood at 13.0% of Revenue, with a 12 Months Growth of +10.2% and a notable +21.9% growth compared to Q1’27.

H1 FY27 Performance

For the first half of fiscal year 2026-27, ending September 2026, Britannia’s Revenue from Operations reached Rs 10,506 Crores, an increase of 13.1% over the 12-month period. The company’s Profit after Tax represented 12.5% of Revenue, with a 12 Months Growth of +11.7%.

Strategic Priorities

The company’s strategic priorities include driving efficiencies in sales, distribution, and supply chain; elevating brand experiences and investments; fostering innovation, adjacencies, and future platforms; winning in diverse Indian markets; and ensuring sustainability. These initiatives are aimed at bolstering continued growth across all channels and strengthening brand relevance.

Input Costs and Revenue Trends

The presentation also touched upon input cost trends, indicating strategic measures to manage costs effectively. Revenue trends were shown to be on an upward trajectory, with 12-month growth rates showing a consistent increase, particularly in the recent quarters, reflecting successful market strategies.

Source: BSE

Previous Article

Sai Life Sciences reports 23% revenue growth in Q2 FY27

Next Article

Cohance Lifesciences site closure follows employee fatality